Product details

This case provides a vehicle to understand the evolution of Edwards Lifesciences (EL) as a leader in the heart valve replacement industry, with solutions for aortic, mitral and tricuspid valves. The company has been at the forefront of innovation specifically in the research, design, manufacturing of multiple generations of valves used in Transcatheter Aortic Valve Replacement (TAVR). The case describes the various components that EL integrated successfully to manage the process of continuous innovation, and to create and deliver outstanding value over an extended period to its customers, partners and shareholders, thereby earning the admiration of analysts and management experts.